nodes	percent_of_prediction	percent_of_DWPC	metapath
Tripelennamine—CYP2D6—Gefitinib—lung cancer	0.302	0.32	CbGbCtD
Tripelennamine—CYP2D6—Vinorelbine—lung cancer	0.233	0.246	CbGbCtD
Tripelennamine—CYP2D6—Erlotinib—lung cancer	0.179	0.189	CbGbCtD
Tripelennamine—CYP2D6—Vinblastine—lung cancer	0.143	0.152	CbGbCtD
Tripelennamine—CYP2D6—Doxorubicin—lung cancer	0.0882	0.0932	CbGbCtD
Tripelennamine—Rosiglitazone—CYP2A6—lung cancer	0.00347	0.203	CrCbGaD
Tripelennamine—Carbinoxamine—CYP2E1—lung cancer	0.00155	0.0905	CrCbGaD
Tripelennamine—Rosiglitazone—ALB—lung cancer	0.00135	0.0792	CrCbGaD
Tripelennamine—Brompheniramine—CYP2E1—lung cancer	0.00134	0.0784	CrCbGaD
Tripelennamine—Tamoxifen—CYP2A6—lung cancer	0.00122	0.0716	CrCbGaD
Tripelennamine—Tamoxifen—ABCG2—lung cancer	0.00109	0.064	CrCbGaD
Tripelennamine—Tamoxifen—CYP2E1—lung cancer	0.000869	0.0508	CrCbGaD
Tripelennamine—Tamoxifen—CYP1A1—lung cancer	0.000857	0.0501	CrCbGaD
Tripelennamine—Orphenadrine—CYP2E1—lung cancer	0.000844	0.0494	CrCbGaD
Tripelennamine—Bepridil—ABCB1—lung cancer	0.000716	0.0419	CrCbGaD
Tripelennamine—Imipramine—CYP2E1—lung cancer	0.000674	0.0394	CrCbGaD
Tripelennamine—Amitriptyline—CYP2E1—lung cancer	0.00067	0.0392	CrCbGaD
Tripelennamine—Tamoxifen—ABCB1—lung cancer	0.000455	0.0267	CrCbGaD
Tripelennamine—Doxepin—ABCB1—lung cancer	0.000454	0.0266	CrCbGaD
Tripelennamine—Methadone—ABCB1—lung cancer	0.000452	0.0264	CrCbGaD
Tripelennamine—Amitriptyline—ALB—lung cancer	0.000368	0.0215	CrCbGaD
Tripelennamine—Imipramine—ABCB1—lung cancer	0.000353	0.0207	CrCbGaD
Tripelennamine—Amitriptyline—ABCB1—lung cancer	0.000351	0.0205	CrCbGaD
Tripelennamine—HRH1—G alpha (q) signalling events—GNG11—lung cancer	0.000245	0.00656	CbGpPWpGaD
Tripelennamine—HRH1—IL-4 Signaling Pathway—PIK3CD—lung cancer	0.000236	0.0063	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—OXTR—lung cancer	0.000234	0.00627	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GRP—lung cancer	0.000234	0.00627	CbGpPWpGaD
Tripelennamine—CYP2D6—Biological oxidations—CYP2A7—lung cancer	0.000227	0.00607	CbGpPWpGaD
Tripelennamine—CYP2D6—Metapathway biotransformation—CYP2A7—lung cancer	0.000224	0.00598	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GNG11—lung cancer	0.000219	0.00587	CbGpPWpGaD
Tripelennamine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	0.000211	0.00564	CbGpPWpGaD
Tripelennamine—HRH1—GPCRs, Class A Rhodopsin-like—OXTR—lung cancer	0.000203	0.00542	CbGpPWpGaD
Tripelennamine—CYP2D6—Biological oxidations—GSTA3—lung cancer	0.000202	0.00541	CbGpPWpGaD
Tripelennamine—CYP2D6—Metapathway biotransformation—GSTA3—lung cancer	0.000199	0.00533	CbGpPWpGaD
Tripelennamine—HRH1—G alpha (q) signalling events—ANXA1—lung cancer	0.000193	0.00516	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—GIPR—lung cancer	0.000189	0.00505	CbGpPWpGaD
Tripelennamine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	0.000187	0.005	CbGpPWpGaD
Tripelennamine—CYP2D6—Biological oxidations—GSTA4—lung cancer	0.000185	0.00495	CbGpPWpGaD
Tripelennamine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—lung cancer	0.000184	0.00493	CbGpPWpGaD
Tripelennamine—HRH1—G alpha (q) signalling events—APP—lung cancer	0.000183	0.00489	CbGpPWpGaD
Tripelennamine—CYP2D6—Metapathway biotransformation—GSTA4—lung cancer	0.000182	0.00488	CbGpPWpGaD
Tripelennamine—CYP2D6—Biological oxidations—GSTA2—lung cancer	0.00018	0.00482	CbGpPWpGaD
Tripelennamine—CYP2D6—Biological oxidations—GSTA1—lung cancer	0.000174	0.00465	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—GRP—lung cancer	0.000174	0.00464	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—OXTR—lung cancer	0.000174	0.00464	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—ANXA1—lung cancer	0.000173	0.00461	CbGpPWpGaD
Tripelennamine—HRH1—IL-4 Signaling Pathway—EP300—lung cancer	0.000169	0.00453	CbGpPWpGaD
Tripelennamine—CYP2D6—Metapathway biotransformation—AKR1C1—lung cancer	0.000164	0.00439	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—APP—lung cancer	0.000164	0.00437	CbGpPWpGaD
Tripelennamine—CYP2D6—Biological oxidations—UGT1A1—lung cancer	0.000162	0.00432	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—GRM8—lung cancer	0.000161	0.00429	CbGpPWpGaD
Tripelennamine—CYP2D6—Metapathway biotransformation—UGT1A1—lung cancer	0.000159	0.00426	CbGpPWpGaD
Tripelennamine—HRH1—IL-4 Signaling Pathway—STAT3—lung cancer	0.000159	0.00425	CbGpPWpGaD
Tripelennamine—HRH1—IL-4 Signaling Pathway—MAPK3—lung cancer	0.000152	0.00406	CbGpPWpGaD
Tripelennamine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	0.000152	0.00405	CbGpPWpGaD
Tripelennamine—HRH1—G alpha (q) signalling events—AVP—lung cancer	0.000142	0.0038	CbGpPWpGaD
Tripelennamine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	0.000139	0.00373	CbGpPWpGaD
Tripelennamine—CYP2D6—Biological oxidations—HPGDS—lung cancer	0.000137	0.00368	CbGpPWpGaD
Tripelennamine—CYP2D6—Biological oxidations—GSTT1—lung cancer	0.000133	0.00356	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—OXTR—lung cancer	0.000132	0.00354	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—GRP—lung cancer	0.000132	0.00354	CbGpPWpGaD
Tripelennamine—CYP2D6—Biological oxidations—GCLC—lung cancer	0.000132	0.00352	CbGpPWpGaD
Tripelennamine—CYP2D6—Biological oxidations—CYP2A6—lung cancer	0.000132	0.00352	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—ANXA1—lung cancer	0.000128	0.00342	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—lung cancer	0.000127	0.0034	CbGpPWpGaD
Tripelennamine—HRH1—IL-4 Signaling Pathway—PIK3CA—lung cancer	0.000125	0.00335	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—GNG11—lung cancer	0.000124	0.00331	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—APP—lung cancer	0.000121	0.00324	CbGpPWpGaD
Tripelennamine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—lung cancer	0.000113	0.00302	CbGpPWpGaD
Tripelennamine—CYP2D6—Biological oxidations—CYP2E1—lung cancer	0.000112	0.003	CbGpPWpGaD
Tripelennamine—CYP2D6—Metapathway biotransformation—CYP2E1—lung cancer	0.000111	0.00296	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—GIPR—lung cancer	0.000107	0.00285	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—PTHLH—lung cancer	0.000103	0.00277	CbGpPWpGaD
Tripelennamine—HRH1—IL-4 Signaling Pathway—AKT1—lung cancer	0.000102	0.00274	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—ANXA1—lung cancer	9.73e-05	0.0026	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—GIPR—lung cancer	9.69e-05	0.00259	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—AVP—lung cancer	9.42e-05	0.00252	CbGpPWpGaD
Tripelennamine—CYP2D6—Biological oxidations—GSTP1—lung cancer	9.24e-05	0.00247	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—APP—lung cancer	9.22e-05	0.00247	CbGpPWpGaD
Tripelennamine—CYP2D6—Metapathway biotransformation—GSTP1—lung cancer	9.11e-05	0.00244	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—GRM8—lung cancer	9.07e-05	0.00243	CbGpPWpGaD
Tripelennamine—CYP2D6—Biological oxidations—GSTM1—lung cancer	8.49e-05	0.00227	CbGpPWpGaD
Tripelennamine—CYP2D6—Metapathway biotransformation—GSTM1—lung cancer	8.38e-05	0.00224	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—lung cancer	8.24e-05	0.0022	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—GRM8—lung cancer	8.24e-05	0.0022	CbGpPWpGaD
Tripelennamine—CYP2D6—Biological oxidations—CYP1A1—lung cancer	8.05e-05	0.00215	CbGpPWpGaD
Tripelennamine—CYP2D6—Metapathway biotransformation—CYP1A1—lung cancer	7.94e-05	0.00212	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAP2K1—lung cancer	7.86e-05	0.0021	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—AXL—lung cancer	7.55e-05	0.00202	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—GRP—lung cancer	7.47e-05	0.002	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—OXTR—lung cancer	7.47e-05	0.002	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—AVP—lung cancer	7.17e-05	0.00192	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—COL4A3BP—lung cancer	7.08e-05	0.00189	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—AZIN2—lung cancer	7.08e-05	0.00189	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—GNG11—lung cancer	6.99e-05	0.00187	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—lung cancer	6.97e-05	0.00186	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—OXTR—lung cancer	6.78e-05	0.00181	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—GRP—lung cancer	6.78e-05	0.00181	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—GNG11—lung cancer	6.35e-05	0.0017	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—ADCY1—lung cancer	6.29e-05	0.00168	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—lung cancer	6.26e-05	0.00167	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ATP5H—lung cancer	6.02e-05	0.00161	CbGpPWpGaD
Tripelennamine—CYP2D6—Biological oxidations—POMC—lung cancer	6e-05	0.0016	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—COL4A2—lung cancer	5.87e-05	0.00157	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—PTHLH—lung cancer	5.85e-05	0.00156	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—GIPR—lung cancer	5.72e-05	0.00153	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—ADCY1—lung cancer	5.71e-05	0.00153	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—PPP2R1B—lung cancer	5.57e-05	0.00149	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—ANXA1—lung cancer	5.5e-05	0.00147	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PLBD1—lung cancer	5.37e-05	0.00143	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—SDC4—lung cancer	5.34e-05	0.00143	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—PTHLH—lung cancer	5.31e-05	0.00142	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—lung cancer	5.24e-05	0.0014	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—DUSP3—lung cancer	5.24e-05	0.0014	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—APP—lung cancer	5.21e-05	0.00139	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—RHEB—lung cancer	5.13e-05	0.00137	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—lung cancer	5.02e-05	0.00134	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—ANXA1—lung cancer	4.99e-05	0.00133	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—HSD17B10—lung cancer	4.91e-05	0.00131	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—GRM8—lung cancer	4.87e-05	0.0013	CbGpPWpGaD
Tripelennamine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—lung cancer	4.84e-05	0.00129	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—lung cancer	4.78e-05	0.00128	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—POMC—lung cancer	4.77e-05	0.00127	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—APP—lung cancer	4.73e-05	0.00127	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—SKI—lung cancer	4.71e-05	0.00126	CbGpPWpGaD
Tripelennamine—HRH1—G alpha (q) signalling events—PIK3CA—lung cancer	4.64e-05	0.00124	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CKB—lung cancer	4.56e-05	0.00122	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—lung cancer	4.51e-05	0.00121	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GSTM2—lung cancer	4.29e-05	0.00115	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CNDP2—lung cancer	4.29e-05	0.00115	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—MTMR3—lung cancer	4.17e-05	0.00112	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—lung cancer	4.15e-05	0.00111	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PXN—lung cancer	4.09e-05	0.00109	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PGAM1—lung cancer	4.07e-05	0.00109	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—AVP—lung cancer	4.05e-05	0.00108	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—GRP—lung cancer	4.01e-05	0.00107	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—OXTR—lung cancer	4.01e-05	0.00107	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—AKR1C1—lung cancer	4.01e-05	0.00107	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CYP2A7—lung cancer	3.88e-05	0.00104	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—lung cancer	3.84e-05	0.00103	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—SDC4—lung cancer	3.8e-05	0.00102	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—GNG11—lung cancer	3.75e-05	0.001	CbGpPWpGaD
Tripelennamine—HRH1—GPCR ligand binding—CXCL8—lung cancer	3.69e-05	0.000986	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—AVP—lung cancer	3.68e-05	0.000984	CbGpPWpGaD
Tripelennamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—lung cancer	3.67e-05	0.000982	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—VEGFC—lung cancer	3.57e-05	0.000955	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—RRM1—lung cancer	3.46e-05	0.000925	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GSTA3—lung cancer	3.46e-05	0.000925	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ADCY1—lung cancer	3.37e-05	0.000902	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PPP2R1B—lung cancer	3.29e-05	0.000879	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—SMARCA4—lung cancer	3.29e-05	0.000879	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—B4GALT5—lung cancer	3.25e-05	0.000869	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HSPB1—lung cancer	3.17e-05	0.000848	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GSTA4—lung cancer	3.16e-05	0.000846	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PTHLH—lung cancer	3.14e-05	0.000839	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GSTA2—lung cancer	3.08e-05	0.000824	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GSTA1—lung cancer	2.97e-05	0.000795	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ANXA1—lung cancer	2.95e-05	0.000788	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ABCC3—lung cancer	2.94e-05	0.000786	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—FLT1—lung cancer	2.86e-05	0.000764	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—AKR1C1—lung cancer	2.85e-05	0.000761	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—PIK3CG—lung cancer	2.83e-05	0.000756	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—APP—lung cancer	2.8e-05	0.000747	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—NOTCH3—lung cancer	2.8e-05	0.000747	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—FGF9—lung cancer	2.77e-05	0.000741	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—UGT1A1—lung cancer	2.76e-05	0.000739	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—POMC—lung cancer	2.69e-05	0.00072	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GNG11—lung cancer	2.67e-05	0.000713	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—JUNB—lung cancer	2.65e-05	0.000708	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—PIK3CG—lung cancer	2.57e-05	0.000687	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ALDOA—lung cancer	2.54e-05	0.000679	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—PIK3CD—lung cancer	2.49e-05	0.000665	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—NCOA3—lung cancer	2.46e-05	0.000659	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—POMC—lung cancer	2.45e-05	0.000654	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—STK11—lung cancer	2.4e-05	0.000643	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ADCY1—lung cancer	2.4e-05	0.000641	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ABCG2—lung cancer	2.4e-05	0.000641	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—IL6R—lung cancer	2.39e-05	0.000638	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ENO2—lung cancer	2.35e-05	0.000629	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—HPGDS—lung cancer	2.35e-05	0.000629	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PPP2R1B—lung cancer	2.34e-05	0.000625	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—FOXO3—lung cancer	2.32e-05	0.00062	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GSTT1—lung cancer	2.28e-05	0.00061	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—MAP2K1—lung cancer	2.27e-05	0.000608	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—PIK3CD—lung cancer	2.26e-05	0.000604	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GCLC—lung cancer	2.25e-05	0.000603	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CYP2A6—lung cancer	2.25e-05	0.000603	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—AVP—lung cancer	2.17e-05	0.000581	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—PIK3CB—lung cancer	2.17e-05	0.00058	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ENO1—lung cancer	2.14e-05	0.000571	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—IGF1R—lung cancer	2.09e-05	0.00056	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—CXCL8—lung cancer	2.08e-05	0.000557	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HES1—lung cancer	2.06e-05	0.00055	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—RAF1—lung cancer	2.02e-05	0.000539	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—IL2—lung cancer	1.99e-05	0.000532	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—PIK3CB—lung cancer	1.97e-05	0.000526	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CYP2E1—lung cancer	1.92e-05	0.000512	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—NQO1—lung cancer	1.89e-05	0.000507	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—CXCL8—lung cancer	1.89e-05	0.000506	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ERBB3—lung cancer	1.88e-05	0.000503	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—IL2—lung cancer	1.81e-05	0.000483	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—TERT—lung cancer	1.8e-05	0.000482	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—FGFR1—lung cancer	1.75e-05	0.000468	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HIF1A—lung cancer	1.72e-05	0.000461	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—STK11—lung cancer	1.71e-05	0.000457	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—APOA1—lung cancer	1.66e-05	0.000445	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—KDR—lung cancer	1.65e-05	0.000441	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GSTP1—lung cancer	1.58e-05	0.000423	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CAT—lung cancer	1.54e-05	0.000411	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PIK3CG—lung cancer	1.52e-05	0.000406	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—KIT—lung cancer	1.52e-05	0.000406	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—APC—lung cancer	1.52e-05	0.000406	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—NRAS—lung cancer	1.52e-05	0.000406	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—EGF—lung cancer	1.5e-05	0.000401	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ABCB1—lung cancer	1.5e-05	0.0004	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—TYMS—lung cancer	1.47e-05	0.000393	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—MAPK3—lung cancer	1.45e-05	0.000389	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—GSTM1—lung cancer	1.45e-05	0.000388	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—POMC—lung cancer	1.44e-05	0.000386	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—BRAF—lung cancer	1.43e-05	0.000381	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—IL6R—lung cancer	1.41e-05	0.000377	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CREBBP—lung cancer	1.41e-05	0.000376	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—EGFR—lung cancer	1.38e-05	0.00037	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CYP1A1—lung cancer	1.38e-05	0.000368	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ERCC2—lung cancer	1.37e-05	0.000365	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—MAP2K1—lung cancer	1.34e-05	0.000359	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PIK3CD—lung cancer	1.33e-05	0.000357	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—PIK3CA—lung cancer	1.32e-05	0.000353	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—KRAS—lung cancer	1.31e-05	0.000349	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—PIK3CA—lung cancer	1.2e-05	0.000321	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—MDM2—lung cancer	1.2e-05	0.00032	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—RAF1—lung cancer	1.19e-05	0.000318	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—APOA1—lung cancer	1.18e-05	0.000316	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—ERBB2—lung cancer	1.18e-05	0.000315	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—MTOR—lung cancer	1.16e-05	0.000311	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PIK3CB—lung cancer	1.16e-05	0.000311	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CXCL8—lung cancer	1.12e-05	0.000299	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—HRAS—lung cancer	1.11e-05	0.000297	CbGpPWpGaD
Tripelennamine—HRH1—GPCR downstream signaling—AKT1—lung cancer	1.08e-05	0.000289	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PIK3CG—lung cancer	1.08e-05	0.000288	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CASP3—lung cancer	1.07e-05	0.000286	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—IL2—lung cancer	1.07e-05	0.000286	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—IL6—lung cancer	1.06e-05	0.000284	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CCND1—lung cancer	1.04e-05	0.000278	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—JUN—lung cancer	1.04e-05	0.000278	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—POMC—lung cancer	1.03e-05	0.000274	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—MMP9—lung cancer	1.01e-05	0.00027	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—CDKN1A—lung cancer	1.01e-05	0.000269	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PTEN—lung cancer	1e-05	0.000269	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—CREBBP—lung cancer	1e-05	0.000267	CbGpPWpGaD
Tripelennamine—HRH1—Signaling by GPCR—AKT1—lung cancer	9.8e-06	0.000262	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—EP300—lung cancer	9.58e-06	0.000256	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PIK3CD—lung cancer	9.48e-06	0.000253	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—ALB—lung cancer	9.36e-06	0.00025	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—SRC—lung cancer	9.32e-06	0.000249	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—VEGFA—lung cancer	9.08e-06	0.000243	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—STAT3—lung cancer	8.99e-06	0.00024	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—NRAS—lung cancer	8.97e-06	0.00024	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—MAPK3—lung cancer	8.59e-06	0.00023	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—MYC—lung cancer	8.35e-06	0.000223	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PIK3CB—lung cancer	8.26e-06	0.000221	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PTGS2—lung cancer	8.19e-06	0.000219	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—EGFR—lung cancer	8.17e-06	0.000218	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—KRAS—lung cancer	7.72e-06	0.000206	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PTEN—lung cancer	7.14e-06	0.000191	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—PIK3CA—lung cancer	7.09e-06	0.00019	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—TP53—lung cancer	6.86e-06	0.000183	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—EP300—lung cancer	6.81e-06	0.000182	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—HRAS—lung cancer	6.56e-06	0.000175	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—IL6—lung cancer	6.28e-06	0.000168	CbGpPWpGaD
Tripelennamine—HRH1—Signaling Pathways—AKT1—lung cancer	5.79e-06	0.000155	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—PIK3CA—lung cancer	5.04e-06	0.000135	CbGpPWpGaD
Tripelennamine—CYP2D6—Metabolism—AKT1—lung cancer	4.11e-06	0.00011	CbGpPWpGaD
